Profile of:

Roberta Ramonda

Professor of Rheumatology- Rheumatology Unit, University Hospital of Padova, Padova-Italy Specialized in Rheumatology and Cardiology and PhD in Rheumatology and Geriatric Experimental and Clinic at the University of Padova. Graduation in Ultrasound Internal Course Member of several Societies (SIR, ACR, GRAPPA, ASAS, OMERACT) She has a long-standing experience in clinical management of Spondyloarthritis patients. The Unit in which she works is a 3rd referral rheumatological Centre, of prominence within Italy, for the diagnosis and management of patients affected with rheumatic conditions. In addition, she has expertise in the management and follow-up of patients with microcrystals diseases, in particular in the evaluation with synovial fluid analysis and ultrasound tool, to develop early diagnosis. However, she has a very high expertise in the study of the erosive osteoarthritis, and Padova is a Regional referral Center. Prof. Ramonda is the author of several papers published in highly regarded ISI journals, including clinical studies describing manifestations or subgroup prognostic risk factors, and therapeutic response to biological treatments in patients with spondyloarthritis, microcrystals diseases and erosive hand osteoarthritis. In addition, she has co-authored of books, and Conference Proceedings and over 500 abstracts to National and International Conferences. She has extensive experience and PI in multiple GCP trials included a HORIZON 2020

Full name: Roberta Ramonda

Current country: Italy

Membership level: Full

Type of membership: Member

Number of publications: 80

The Risk of overdiagnosis and overtreatment in spondyloarthritis. (2022)

Measuring quality of life of patients with axial spondyloarthritis for economic evaluation (2022)

Editorial: Genetic Studies on Spondyloarthritis: From Disease Predictors to Therapeutic Targets (2022)

Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients: A 24-Month Real-Life Study (2022)

Effectiveness and safety of secukinumab in axial spondyloarthritis: a 24-month prospective, multicenter real-life study (2022)

Do we believe in non-radiographic axial spondyloarthritis? A debate (2021)

Quality of life and therapeutic management of axial spondyloarthritis patients in Italy: a 12-month prospective observational study (2021)

SARS-CoV-2 Infection in Spondyloarthritis Patients Treated With Biotechnological Drugs: A Study on Serology (2021)

The Genetic Contribution to Drug Response in Spondyloarthritis: A Systematic Literature Review (2021)

Mediterranean diet in axial spondyloarthritis: an observational study in an Italian monocentric cohort (2021)

Lifestyle Factors and Disease Activity Over Time in Early Axial Spondyloarthritis: The SPondyloArthritis Caught Early (SPACE) Cohort (2021)

Psoriasis and Imaging Progression in early Axial Spondyloarthritis: Results from a 48-month follow-up (Italian arm of SPACE study) (2021)

An Italian Disease-Based Registry of Axial and Peripheral Spondyloarthritis: The SIRENA Study (2021)

Sex-associated and gender-associated differences in the diagnosis and management of axial spondyloarthritis: addressing the unmet needs of female patients (2021)

Do obesity and overweight influence disease activity measures in axial spondyloarthritis? A systematic review and meta-analysis (2020)

An update on serum biomarkers to assess axial spondyloarthritis and to guide treatment decision (2020)

Do Illness Perceptions and Coping Strategies Change Over Time in Patients Recently Diagnosed With Axial Spondyloarthritis? (2020)

Spine and Sacroiliac Joints Lesions on Magnetic Resonance Imaging in Early Axial-Spondyloarthritis During 24-Months Follow-Up (Italian Arm of SPACE Study) (2020)

Golimumab effectiveness in biologic inadequate responding patients with rheumatoid arthritis, psoriatic arthritis and spondyloarthritis in real-life from the Italian registry GISEA (2020)

Improvement of Function and Its Determinants in a Group of Axial Spondyloarthritis Patients Treated with TNF Inhibitors: A Real-Life Study (2020)

Low specificity but high sensitivity of inflammatory back pain criteria in rheumatology settings in Europe: confirmation of findings from a German cohort study (2019)

Observational study on the QUality of life of Italian Axial SpondyloARthritis patients (QUASAR): baseline data (2019)

Rate of serious infections in spondyloarthropathy patients treated with anti-tumour necrosis factor drugs: a survey from the Italian registry GISEA (2019)

Red flags for appropriate referral to the gastroenterologist and the rheumatologist of patients with inflammatory bowel disease and spondyloarthritis (2019)

Is it Useful to Repeat Magnetic Resonance Imaging of the Sacroiliac Joints After Three Months or One Year in the Diagnosis of Patients With Chronic Back Pain and Suspected Axial Spondyloarthritis? (2019)

Radiologist-rheumatologist multidisciplinary approach in the management of axial spondyloarthritis: a Delphi consensus statement (2018)

Are gender-specific approaches needed in diagnosing early axial spondyloarthritis? Data from the SPondyloArthritis Caught Early cohort (2018)

Frequency of Impaired Spinal Mobility in Patients with Chronic Back Pain Compared to Patients with Early Axial Spondyloarthritis (2018)

The Impact of Illness Perceptions and Coping on the Association Between Back Pain and Health Outcomes in Patients Suspected of Having Axial Spondyloarthritis: Data From the SPondyloArthritis Caught Early Cohort (2018)

Impact of replacing radiographic sacroiliitis by magnetic resonance imaging structural lesions on the classification of patients with axial spondyloarthritis (2018)

Imaging of the sacroiliac joints is important for diagnosing early axial spondyloarthritis but not all-decisive (2018)

Genetics in TNF-TNFR pathway: A complex network causing spondyloarthritis and conditioning response to anti-TNFα therapy (2018)

n Early Axial Spondyloarthritis, Increasing Disease Activity Is Associated with Worsening of Health-related Quality of Life over Time (2018)

Magnetic Resonance Imaging of the Sacroiliac Joints Indicating Sacroiliitis According to the Assessment of SpondyloArthritis international Society Definition in Healthy Individuals, Runners, and Women With Postpartum Back Pain (2018)

Anti-CD74 antibodies have no diagnostic value in early axial spondyloarthritis: data from the spondyloarthritis caught early (SPACE) cohort (2018)

ncidence of cancer in patients with spondyloarthritis treated with anti-TNF drugs (2018)

Disease activity decrease is associated with improvement in work productivity over 1 year in early axial spondyloarthritis (SPondyloArthritis Caught Early cohort) (2017)

The Sex Influence on Response to Tumor Necrosis Factor-α Inhibitors and Remission in Axial Spondyloarthritis (2017)

Biomarkers, imaging and disease activity indices in patients with early axial spondyloarthritis: the Italian arm of the SpondyloArthritis-Caught-Early (SPACE) Study (2017)

The yield of a positive MRI of the spine as imaging criterion in the ASAS classification criteria for axial spondyloarthritis: results from the SPACE and DESIR cohorts (2017)

Spondyloarthritis: Matrix Metalloproteinasesas Biomarkers of Pathogenesis and Response to Tumor Necrosis Factor (TNF) Inhibitors (2017)

The influence of discrepant imaging judgements on the classification of axial spondyloarthritis is limited: a replication in the SpondyloArthritis Caught Early (SPACE) cohort (2017)

Serum inflammatory biomarkers fail to identify early axial spondyloarthritis: results from the SpondyloArthritis Caught Early (SPACE) cohort (2017)

Bone edema of the whole vertebral body: an unusual case of spondyloarthritis (2017)

Is the current ASAS expert definition of a positive family history useful in identifying axial spondyloarthritis? Results from the SPACE and DESIR cohorts (2017)

Is the Site of Back Pain Related to the Location of Magnetic Resonance Imaging Lesions in Patients With Chronic Back Pain? Results From the Spondyloarthritis Caught Early Cohort (2017)

Work productivity is associated with disease activity and functional ability in Italian patients with early axial spondyloarthritis: an observational study from the SPACE cohort (2016)

Are Additional Tests Needed to Rule Out Axial Spondyloarthritis in Patients Ages 16-45 Years With Short-Duration Chronic Back Pain and Maximally One Spondyloarthritis Feature? (2016)

Spine and sacroiliac joints on magnetic resonance imaging in patients with early axial spondyloarthritis: prevalence of lesions and association with clinical and disease activity indices from the Italian group of the SPACE study (2016)

Does body mass index (BMI) influence the Ankylosing Spondylitis Disease Activity Score in axial spondyloarthritis?: Data from the SPACE cohort (2016)

Predictors of Loss of Remission and Disease Flares in Patients with Axial Spondyloarthritis Receiving Antitumor Necrosis Factor Treatment: A Retrospective Study (2016)

Patient-reported impact of spondyloarthritis on work disability and working life: the ATLANTIS survey (2016)

The clinical relevance of early anti-adalimumab antibodies detection in rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: A prospective multicentre study (2016)

Patients with chronic back pain of short duration from the SPACE cohort: which MRI structural lesions in the sacroiliac joints and inflammatory and structural lesions in the spine are most specific for axial spondyloarthritis? (2016)

How the Mediterranean diet and some of its components modulate inflammatory pathways in arthritis (2015)

Predictors of response and drug survival in ankylosing spondylitis patients treated with infliximab (2015)

The -308 TNFα and the -174 IL-6 promoter polymorphisms associate with effective anti-TNFα treatment in seronegative spondyloarthritis (2015)

Metric Properties of the SPARCC Score of the Sacroiliac Joints – Data from Baseline, 3-month, and 12-month Followup in the SPACE Cohort (2015)

Remission in nonradiographic axial spondyloarthritis treated with anti-tumor necrosis factor-α drugs: an Italian multicenter study (2014)

Predictive factors for partial remission according to the Ankylosing Spondylitis Assessment Study working group in patients with ankylosing spondylitis treated with anti-TNFα drugs (2014)

The adherence to ASAS classification criteria and to ASAS recommendations for the use of anti-TNH-alpha agents in axial spondyloarthritis (2014)

Influence of tumor necrosis factor α inhibitors on testicular function and semen in spondyloarthritis patient (2014)

Atherosclerosis progression in psoriatic arthritis patients despite the treatment with tumor necrosis factor-alpha blockers: a two-year prospective observational study (2014)

Supervised training and home-based rehabilitation in patients with stabilized ankylosing spondylitis on TNF inhibitor treatment: a controlled clinical trial with a 12-month follow-up (2014)

Long-term safety of anti-TNF-α in PsA patients with concomitant HCV infection: a retrospective observational multicenter study on 15 patients (2014)

Impact of 24-month treatment with etanercept, adalimumab, or methotrexate on metabolic syndrome components in a cohort of 210 psoriatic arthritis patients (2014)

Impact of hypertension on vascular remodeling in patients with psoriatic arthritis (2014)

Serological markers in psoriatic arthritis: promising tools (2013)

Remission in ankylosing spondylitis treated with anti-TNF-α drugs: a national multicentre study (2013)

The effects of combined spa therapy and rehabilitation on patients with ankylosing spondylitis being treated with TNF inhibitors (2013)

Infection relapse in spondyloarthritis treated with biological drugs: a single-centre study (2012)

Anterior chest wall involvement in early stages of spondyloarthritis: advanced diagnostic tools (2012)

Psoriatic arthritis. When the heterogeneity requires normality (2012)

Atherosclerosis in psoriatic arthritis (2011)

Rehabilitation treatment in patients with ankylosing spondylitis stabilized with tumor necrosis factor inhibitor therapy: a randomized controlled trial (2011)

Multiple paradoxical adverse events in a patient affected with ankylosing spondylitis treated with TNF blockers (2011)

Sensorineural hearing loss in ankylosing spondylitis treated with TNF blockers (2010)

Switching from infliximab or etanercept to adalimumab in resistant or intolerant patients with spondyloarthritis: a 4-year study (2010)

[Subclinical atherosclerosis in patients with psoriatic arthritis: a case-control study. Preliminary data (2009)

Association of MICA alleles with psoriatic arthritis and its clinical forms. A multicenter Italian study (2008)